In the Pten mouse, the number of RPKM for Sdc1 was compatible with increased expression across stages of tumor progression, in PIN lesions, and at medium and advanced stages (Figure 1C). This evidence concerns the gene SDC1 and prostate intraepithelial neoplasia.